Principal Full Stack Engineer, Ginkgo Bioworks

Ginkgo Bioworks sells programmable cell development services to provide access to the technology to industries outside of medicine. Whilst the company has already worked on medical products such as vaccines for Moderna, it will research and design products based on programmed cells for any product that it believes holds value.

The startup’s approach to providing cell programming services outside of the medical sector is smart, as an increasingly high number of industries recognize the potential for bespoke cell-based materials. Ginkgo also provides an opportunity for innovation where it previously was not possible by taking the research and design into its own hands where companies would usually need to facilitate such services within their company.